Diagnostic and Interventional Cardiology

CardiAMP cell therapy-treated patients had 37% relative risk reduction in heart death equivalent (death, heart transplant, left ventricular assist device implantation) and 9% relative risk reduction in non-fatal major adverse cardiac and cerebrovascular events

News | FDA

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

March 7, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions for ...

March 07, 2024

The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd Annual Scientific Session & Expo, ACC.24, including U.S. Food and Drug Administration Commissioner Robert M. Califf, MD, MACC, among a host of highly-regarded cardiovascular thought leaders and practitioners during the April 6-8 meeting in Atlanta, GA.

News | ACC

FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

March 07, 2024

Matt Renner, President of North America and Global Startups at Google Cloud, is one of several keynote to be featured during the HIMSS 2024, the Global Conference and Exhibition of the Healthcare Information and Management Systems Society (HIMSS) to be held March 11-15 in Orlando, FL.

News | HIMSS

Google Cloud Leader and High-Profile Keynote Speakers to be Featured at HIMSS24

March 7, 2024 — With just days to go before HIMSS 2024, the Global Conference and Exhibition of the Healthcare ...

March 07, 2024

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

Among the many notable trends in CT, one of the fastest growing is the coronary CT angiography market, as witnessed at RSNA23

Feature | CT Angiography (CTA) | By Melinda Taschetta-Millane

The Evolving Computed Tomography Market

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

March 07, 2024

An AMA letter sent to Secretary Bacerra outlines ongoing concerns of physicians amidst the cybersecurity incident that has impacted Change Healthcare

News | Cybersecurity

As Cyberattack Jeopardizes Physician Practices, AMA Demands Action

March 6, 2024 — As the cyber-takedown of Change Healthcare has forced medical practices to go without revenue for a ...

March 06, 2024

Company’s AI-enabled technology for future heart attack risk assessment accepted into FDA’s TAP Pilot and to be validated in landmark TRANSFORM trial

News | FDA

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

March 6, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...

March 06, 2024

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Designation for their ECGvision-TTR Technology

News | FDA

Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy

March 6, 2024 — Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of ...

March 06, 2024

Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.

News | Cardiovascular Clinical Studies

Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from ...

March 06, 2024

Lantheus announced that the U.S. Food and Drug Administration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.

News | FDA

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

March 06, 2024

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Feature | PACS | By Melinda Taschetta-Millane

The Emergence of Cloud-based PACS, and Other Trends

Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital ...

March 06, 2024

Feature

One on One ... with Hal Wolf, FHIMSS

Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems ...

March 06, 2024

A look at DAIC's top-viewed content for February 2024

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

A Look at February's Top 10

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

March 05, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Sponsored Content | Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

NIH-funded observational study shows risk grows sharply with more frequent use

News | Stroke

Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

March 05, 2024

Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow

News | Stroke

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

March 05, 2024